Middle Cerebral To Umbilical Artery Doppler Ratio And Amniotic Fluid Volume Measurement In Post-date Pregnancies in King Khalid Military Central City
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this study is to assess the values of MCA PI / UA PI and MCA RI / UA RI ratios and amniotic fluid volume in predicting the adverse perinatal fetal outcome in uncomplicated postdate pregnancy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2014
CompletedFirst Posted
Study publicly available on registry
October 3, 2014
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFebruary 14, 2022
January 1, 2022
1.2 years
September 26, 2014
January 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse pregnancy outcome
at time of delivery
Study Arms (2)
Group 1(Control Group):
ultrasound and Doppler examination: of 100 pregnant females with gestational age 37-40 weeks.
Group 2 (post date Group)
ultrasound and Doppler examination:will be done for 100 pregnant females with gestational age 41 weeks or more
Interventions
ultrasound and Doppler examination: Trans-abdominal ultrasound examination will be peformed to all patienst while women in a slightly tilted position with the head of the bed raised 30 degrees and with a small pillow under the right lion
Eligibility Criteria
Two hundred pregnant women will be recruited from outpatient clinic. Starting from February 2022. An informed consent will be obtained from the patients . The patients will be subdivided into two groups: Group 1(Control Group):consist of 100 pregnant females with gestational age 37-40 weeks. Group 2 (post date Group):consist of 100 pregnant females with gestational age 41 weeks or more.
You may qualify if:
- Singleton, viable fetus in the vertex presentation
- History of regular menstrual cycles
- Gestational age calculated from the first day of last menstryal period or by first-trimester or second-trimester (before 20 weeks) ultrasound examination
- No obstetric or medical complications of pregnancy apart from post-date pregnancy
You may not qualify if:
- Patients unsure of their dates
- Medical disorders with pregnancy as (hypertension, diabetes mellitus or Rh isoimmunization)
- Prelabor rupture of membranes
- Polyhydramnios
- Women with multiple pregnancy
- Congenital fetal anomalies
- Antepartum hemorrhage
- Previus cesarean section
- Fetal malpresentation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
AFHSR
Khamis Mushait, Afhsa, 10018, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
khalid ibrahim, MD
Armed Forces Hospitals, Southern Region, Saudi Arabia
- STUDY DIRECTOR
KHALID IBRAHIM, MD
Armed Forces Hospitals, Southern Region, Saudi Arabia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer and consultant of oblgyne
Study Record Dates
First Submitted
September 26, 2014
First Posted
October 3, 2014
Study Start
February 1, 2022
Primary Completion
May 1, 2023
Study Completion
August 1, 2023
Last Updated
February 14, 2022
Record last verified: 2022-01